DiaSys CorpOver The Counter Market:DYXC
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
DiaSys Corp | 2.6K | 0.0x | --- |
Healthtech Solutions Inc | 9.6K | 0.0x | --- |
BG Medicine Inc | 10.0 | 0.0x | --- |
Montvale Technologies Inc | 10.0 | 0.0x | --- |
Electromedical Technologies Inc | 342.0K | -0.1x | --- |
QHSLab Inc | 868.3K | -4.3x | --- |
Company Information
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Contact Information
- Headquarters
- 21 West Main StreetWATERBURY, CT, United States 06702-2013
- Phone
- 302-636-5400
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Financial Officer
- Morris Silverman
- President, Interim Chief Executive Officer
- Frederic Neikrug
- Secretary, Director
- Robert Wigoda
- Director
- Sherwin Gilbert
- Director
- Sherman Lazrus
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6K |
|---|---|
Revenue (TTM) | $1.6M |
Shares Outstanding | 25.7M |
DiaSys Corp does not pay a dividend. | |
Beta | --- |
EPS | $-0.03 |
Book Value | $0.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -42.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
